Bush, Gore Committed to Medical Record Integrity and Privacy; Anonymous Data Corporation Cites Political Candidate Support for Security of Medical Records.

Business Editors & Health/Medical Writers

LAS VEGAS--(BUSINESS WIRE)--Sept. 22, 2000

Medical privacy issues have become such a key concern for voters that both presidential candidates have come out strongly in favor of solving this problem.

Executives of Anonymous Data Corporation (OTCBB:ANYD) cited the statements of Vice President Al Gore and Governor George W. Bush in favor of privacy of medical records as evidence of the need for biometric technology.

Executives of ANYD point out that the company's patents cover the use of biometrics in keeping medical test results secure. Through the use of electronic fingerprints and digital facial recognition, a patient's identity and medical testing results will remain completely anonymous, thus eliminating any possibility of leakage.

The first of such systems is being installed in a medical laboratory in Las Vegas.

While speaking at a Los Angeles-area community center this week, Gore said legal restrictions must be imposed to protect the sanctity of an individual's medical records.

"It is wrong for the insurance and drug companies to sell your medical information, putting profits ahead of people," said Gore. "You have a fundamental right to privacy, and no powerful interest should be allowed to sell it or take it away."

One area where improper disclosure of medical data can be particularly harmful is genetic testing results. Gore added that the mapping of the human genome would certainly help people who are genetically predisposed to certain diseases; however, the problem lies in disclosure.

"What happens when you can take a single hair from someone and find out the entire genetic makeup of that individual, including whether or not there is a 10 percent higher than normal risk for lung cancer? Is that going to affect insurance rates?" asked Gore.

Governor Bush has kept patient protection and medical privacy in the forefront while serving as governor of Texas. In 1997 and in 1999, he signed and supported five separate bills that have been called the best patient protection laws in the country.

"Al Gore should take note of how Texas is a national leader on patient protections under Governor Bush's leadership," said Bush spokesman Dan Bartlett. "As President, Governor Bush will enact comprehensive patient protections similar to those already enacted in Texas."

Other areas where ANYD executives believe political support is strong for biometrics include prevention of fraud in government insurance and disability payments.

"We're very encouraged to see both presidential candidates making medical privacy issues a major addition to their campaigns," said Dr. James E. Beecham, president of Anonymous Data Corporation.

Beecham, a medical doctor, filed the original patents on biometrics and medical testing in 1996, which have been granted by the U.S. patent office.

Beecham believes that additional areas in biometrics that will play significant roles in the future include judicial records and court proceedings, protection of electronic signatures and identity, fraud prevention and financial transactions.

Anonymous Data Corporation is also the sole source manufacturer of the JL1000 and JL2000 biometric-based computer network solutions for medical laboratories and courts.

Further information about Anonymous Data Corporation and its products can be accessed at http://www.adcx.com.

Statements contained in this release that are not strictly historical are forward-looking within the meaning of the safe harbor clause of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that such forward-looking statements involve risk and uncertainties that may cause the company's actual results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to, demand for the company's product both domestically and abroad, the company's ability to continue to develop its market, general economic conditions and other factors that may be more fully described in the company's literature and periodic filings with the Securities and Exchange Commission.